skip to Main Content

June 26, 2019, Wednesday: Your Celgene Stock – Hold, Sell, or Gift? What Each Choice Could Mean for You

< 1 min read

An informational session with RegentAtlantic Chad O’Brien, CFP®, FRM and Abby Rosen, CFP®, MS

Bristol-Myers Squibb’s acquisition of Celgene may generate a significant tax burden for Celgene stockholders.

Join our 30 minute webinar

Click a time below to register

This session is not a substitute for personalized advice from RegentAtlantic. Please be sure to consult with your tax or legal advisors.

Back To Top